0.565
Collplant Biotechnologies Ltd stock is traded at $0.565, with a volume of 130.47K.
It is down -0.35% in the last 24 hours and down -70.97% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$0.567
Open:
$0.558521
24h Volume:
130.47K
Relative Volume:
1.92
Market Cap:
$7.23M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-0.4631
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
-8.25%
1M Performance:
-70.97%
6M Performance:
-80.58%
1Y Performance:
-83.86%
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CLGN
Collplant Biotechnologies Ltd
|
0.565 | 7.26M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
CollPlant secures Korean patent for dermal filler technology - Investing.com South Africa
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - PR Newswire
CollPlant launches BioFlex bioink kit for 3D bioprinting By Investing.com - Investing.com India
CollPlant Launches BioFlex rhCollagen Bioink Kit to Advance 3D Bioprinting - TipRanks
CollPlant’s BioFlex kit speeds 3D-printed human tissue models - Stock Titan
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - Finviz
What’s the outlook for CollPlant Biotechnologies Ltd.’s sectorRate Hike & High Win Rate Trade Alerts - mfd.ru
CollPlant Moves to Capture GLP-1-Driven Aesthetic Market With Photocurable rhCollagen Filler - TipRanks
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - marketscreener.com
New rhCollagen filler targets faces thinned by GLP-1 weight loss - Stock Titan
What is CollPlant Biotechnologies Ltd. s debt to equity ratioJuly 2025 Sentiment & Weekly High Conviction Ideas - mfd.ru
A | Does CollPlant Biotechnologies Ltd. stock have upside surprise potential - mfd.ru
Will CollPlant Biotechnologies Ltd. stock rally after Fed decisionsJuly 2025 Review & Daily Stock Momentum Reports - mfd.ru
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit? - Yahoo Finance
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com Australia
CollPlant Biotechnologies Raises $2 Million in Registered Direct Offering with Concurrent Warrant Placement - TipRanks
This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday - Benzinga
CollPlant (CLGN) to raise about $2.0M via direct share sale and warrants - Stock Titan
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering - Yahoo Finance
United States shares lower at close of trade; Dow Jones Industrial Average down 1.20% By Investing.com - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.20% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.20% - Investing.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
CollPlant (CLGN) Announces Stock Offering and Private Placement - GuruFocus
CollPlant raises $2M, sells 1.6M shares and issues warrants - Stock Titan
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING - Yahoo Finance
Does CollPlant Biotechnologies Ltd. stock have upside surprise potentialTrade Signal Summary & Daily Entry Point Trade Alerts - mfd.ru
Is CollPlant Biotechnologies Ltd. stock oversold or undervaluedCup and Handle Formations & Connect With Bulls, Avoid the Bears - Bollywood Helpline
Surprises Report: Can CollPlant Biotechnologies Ltd sustain earnings growthRisk Management & Target Return Focused Stock Picks - baoquankhu1.vn
CollPlant Biotechnologies Up 14%, But Some Insiders Miss Out - simplywall.st
Momentum Shift: What technical signals suggest for CollPlant Biotechnologies Ltd stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - Bộ Nội Vụ
Aug Selloffs: Will Unisys Corporation stock go up in YEAR2025 Fundamental Recap & Risk Controlled Daily Plans - baoquankhu1.vn
How institutional buying supports CollPlant Biotechnologies Ltd. stockDay Trade & Verified Technical Trade Signals - Улправда
How sustainable is CollPlant Biotechnologies Ltd. stock dividend payoutRecession Risk & Free Fast Entry Momentum Trade Alerts - Улправда
Is CollPlant Biotechnologies Ltd. stock positioned well for digital economyQuarterly Portfolio Review & Low Risk Entry Point Guides - Улправда
What insider trading reveals about CollPlant Biotechnologies Ltd. stockWeekly Profit Recap & Low Drawdown Trading Strategies - Улправда
Is Nuvation Bio Inc. stock positioned for long term growth2025 Major Catalysts & Technical Pattern Recognition Alerts - Улправда
Is Packaging Corporation of America stock overvalued by current metricsJuly 2025 Sentiment & Risk Managed Investment Entry Signals - Улправда
2026 world cup usa national team final top scorers pressing system knockout prediction guideJuly 2025 Rallies & Verified Entry Point Signals - Улправда
Will CollPlant Biotechnologies Ltd. stock recover faster than marketCPI Data & Daily Market Momentum Tracking - Улправда
Downgrade Watch: What insider trading reveals about CollPlant Biotechnologies Ltd. stockJuly 2025 Sentiment & Weekly High Conviction Ideas - Улправда
Can CollPlant Biotechnologies Ltd. stock maintain operating marginsDollar Strength & Accurate Buy Signal Notifications - ulpravda.ru
Is CollPlant Biotechnologies Ltd. stock attractive for hedge fundsEarnings Overview Summary & Safe Capital Growth Plans - ulpravda.ru
What margin trends mean for Distoken Acquisition Corporation stockM&A Rumor & Daily Technical Stock Forecast Reports - ulpravda.ru
Is CollPlant Biotechnologies Ltd. stock cheap at current valuationMarket Growth Review & Long Hold Capital Preservation Tips - ulpravda.ru
Why H FARM S.p.A. (5JQ) stock could break out in 2025Weekly Trading Summary & AI Driven Stock Movement Reports - Улправда
Sector Leaders Rotate Capital Into Pacheli Industrial Finance LimitedPrice Gap Trading Strategies & Low Entry Capital Stocks - Bollywood Helpline
Bollinger Band Squeeze Points to Volatility in Credent Global Finance LimitedFederal Reserve Announcements & Minimal Investment Trading Tips - Bollywood Helpline
CollPlant Biotechnologies Ltd.Ordinary Shares (NQ: CLGN - FinancialContent
Weekly Trades: Will RedHill Biopharma Ltd Common Stock 2RH stock return to pre crash levels - moha.gov.vn
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):